4th Glioblastoma Drug Development Summit

Kongressthemen
Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS Tumors
Glioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/1427445-2?pid=4832

Speakers: Adilia Hormigo, Professor in the Department of Neurology, Medicine (Division of Hematology- Oncology), Albert Einstein College of Medicine, and more.

https://go.evvnt.com/1427445-3?pid=4832

Frau Aarti Diwan